Efficacy thresholds and target populations for antiviral COVID-19 treatments to save lives and costs: a modelling studyResearch in context

Summary: Background: In 2023 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared endemic, yet hospital admissions have persisted and risen within populations at high and moderate risk of developing severe disease, which include those of older age, and those with co-morbidities...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Epke A. Le Rutte, Andrew J. Shattock, Inês Marcelino, Sophie Goldenberg, Melissa A. Penny
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2024-07-01
Цуврал:	EClinicalMedicine
Нөхцлүүд:	SARS-CoV-2 Treatment Transmission modelling Economic and public health impact
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2589537024002621
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!